Shanghai Haohai Biological Technology Co Ltd Environmental Analytics
Environmental and financial analysis dashboard for Shanghai Haohai Biological Technology Co Ltd. Industry: MANUFACTURING
Company Overview for Shanghai Haohai Biological Technology Co Ltd
Highlights
Showing data for FY2022
Operational Environmental Cost
$4.97m
Operational Environmental Cost Intensity
1.64%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$1.05m
Decoupling Rate (2020-2022)
7.91%
Adjusted EBITDA
$59m
Adjusted EBITDA Margin
20%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 32.14% | -1.44% | 20.47% | ||
| 0.35% | 0.34% | 0.30% | 0.30% | |
| 35.76% | -7.25% | 14.65% | ||
| 1.59% | 1.59% | 1.34% | 1.25% | |
| $4m | $5m | $5m | $6m | |
| 35.11% | -6.22% | 15.73% | ||
| 1.94% | 1.93% | 1.64% | 1.55% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
20%
Adjusted EBIT Margin
9.93%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$203m | $275m | $303m | $372m | |
| 35.59% | 10.19% | 22.78% | ||
$142m | $188m | $238m | $271m | |
| 70.19% | 68.55% | 78.72% | 72.92% | |
$60m | $86m | $64m | $101m | |
| 29.81% | 31.45% | 21.28% | 27.08% | |
$40m | $61m | $35m | $73m | |
| 19.78% | 22.15% | 11.57% | 19.57% | |
| ENVIRONMENTAL COST DATA | ||||
$4m | $5m | $5m | $6m | |
| 1.94% | 1.93% | 1.64% | 1.55% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$56m | $81m | $59m | $95m | |
| 27.87% | 29.52% | 19.63% | 25.53% | |
$36m | $56m | $30m | $67m | |
| 17.84% | 20.22% | 9.93% | 18.02% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF MEDICAL AND DENTAL INSTRUMENTS AND SUPPLIES
Scope 1 (% of Sales)
0.30%
Scope 2 (% of Sales)
1.34%
Operational Environmental Cost Intensity
1.64%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Shanghai Haohai Biological Technology Co Ltd | CN | $5m | 1.64% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022